06/04/2025
3:02 PM | Fate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/30/2025
5:54 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
5:55 PM | Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
4:15 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
11:27 AM | Fate Therapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SCHEDULE 13G | |
04/23/2025
7:39 PM | BlackRock, Inc. (Filed by)
Fate Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/17/2025
3:05 PM | Fate Therapeutics (Filer)
| Form DEF 14A | |
04/17/2025
3:07 PM | Fate Therapeutics (Filer)
| Form DEFA14A | |
04/17/2025
3:09 PM | Fate Therapeutics (Filer)
| Form ARS | |
04/07/2025
3:01 PM | Fate Therapeutics (Filer)
| Form PRE 14A | |
03/06/2025
12:52 PM | Fate Therapeutics (Subject)
Wolchko J Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for FATE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Fate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/16/2025
5:31 PM | Bressi Jerome Charles (Reporting)
Fate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:32 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:36 PM | Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:05 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:06 PM | Bressi Jerome Charles (Reporting)
Fate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
2:12 PM | Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
2:12 PM | Bressi Jerome Charles (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
2:20 PM | Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
8:00 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SCHEDULE 13D/A | |
12/26/2024
8:00 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
8:00 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
8:00 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
1:33 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:50 PM | Fate Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
10/25/2024
8:37 PM | Boxer Capital Management, LLC (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
08/30/2024
3:21 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:01 PM | Fate Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
9:34 AM | Fate Therapeutics (Subject)
Xu Yuan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
4:59 PM | Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2024
5:00 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
5:01 PM | Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
5:05 PM | Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:03 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
